Dr. John Robert Pollard, MD

Dr. Pollard practices at ChristianaCare Wilmington Hospital in Wilmington, Delaware.

Dr. Pollard's NPI, 1932131265, was assigned on July 7, 2006. Dr. Pollard graduated from Perelman School of Med at the University of Pennsylvania in 1999. Dr. Pollard holds Delaware license C1-0011895.

Dr. Pollard's primary practice is ChristianaCare Wilmington Hospital, at 501 W 14th St, Wilmington, DE 19801 in New Castle County. The practice phone is (302) 733-1000.

Dr. Pollard's primary practice is ChristianaCare Wilmington Hospital in Wilmington, Delaware. Dr. Pollard is also affiliated with Christiana Hospital. The medical group on file is ChristianaCare. Dmand AI also links Dr. Pollard to 3 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pollard practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Pollard's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Pollard's licenses on file in 2 states: Delaware and Pennsylvania.

CMS data shows 562 Medicare services from Dr. Pollard across 8 procedure codes in 2024, for 388 Medicare patients. Medicare paid $47,558 for them.

CMS counts 388 Medicare patients who saw Dr. Pollard in 2024. The largest group is 65 to 74, with 144 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pollard's median patient age at 55, with 51% women.

In 2024, Dr. Pollard wrote 2,185 Medicare Part D claims for 305 patients. 74% of them were for generic drugs. CMS names the drug for 2,044 of them, across 32 drugs with 11 or more claims each, at $941,030 in total drug cost. In 2023, CMS named 1,941 claims across 31 drugs.

Dr. Pollard accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pollard as offering telehealth.

Dmand AI links 55 papers to Dr. Pollard, published from 2010 to 2025. 2019 was the busiest year, with 5. The most frequent topics are Anticonvulsants, Ataxia Telangiectasia Mutated Proteins and Pyrazines. Dr. Pollard has published most often in Epilepsy Curr. Dr. Pollard's most frequent co-authors are Michel J. Berg, MD, Gregory L. Krauss, MD and Brian Litt, MD.

CMS Open Payments shows 73 general payments to Dr. Pollard from 20 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 56% of the total. Neurelis, Inc. paid the most, $5,498.

Dr. Pollard graduated from Perelman School of Med at the University of Pennsylvania in 1999.